These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 29794138

  • 1. Decline in arylsulfatase B expression increases EGFR expression by inhibiting the protein-tyrosine phosphatase SHP2 and activating JNK in prostate cells.
    Bhattacharyya S, Feferman L, Han X, Ouyang Y, Zhang F, Linhardt RJ, Tobacman JK.
    J Biol Chem; 2018 Jul 13; 293(28):11076-11087. PubMed ID: 29794138
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity and Leads to Transcriptional Effects through Sustained Phosphorylation of Transcription Factor MITF.
    Bhattacharyya S, Feferman L, Tobacman JK.
    PLoS One; 2016 Jul 13; 11(4):e0153463. PubMed ID: 27078017
    [Abstract] [Full Text] [Related]

  • 3. Decline in arylsulfatase B leads to increased invasiveness of melanoma cells.
    Bhattacharyya S, Feferman L, Terai K, Dudek AZ, Tobacman JK.
    Oncotarget; 2017 Jan 17; 8(3):4169-4180. PubMed ID: 27926479
    [Abstract] [Full Text] [Related]

  • 4. Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects.
    Bhattacharyya S, Feferman L, Tobacman JK.
    Oncogene; 2014 Nov 20; 33(47):5467-76. PubMed ID: 24240681
    [Abstract] [Full Text] [Related]

  • 5. Regulation of chondroitin-4-sulfotransferase (CHST11) expression by opposing effects of arylsulfatase B on BMP4 and Wnt9A.
    Bhattacharyya S, Feferman L, Tobacman JK.
    Biochim Biophys Acta; 2015 Mar 20; 1849(3):342-52. PubMed ID: 25511584
    [Abstract] [Full Text] [Related]

  • 6. Arylsulfatase B (N-acetylgalactosamine-4-sulfatase): potential role as a biomarker in prostate cancer.
    Feferman L, Bhattacharyya S, Deaton R, Gann P, Guzman G, Kajdacsy-Balla A, Tobacman JK.
    Prostate Cancer Prostatic Dis; 2013 Sep 20; 16(3):277-84. PubMed ID: 23835622
    [Abstract] [Full Text] [Related]

  • 7. Exogenous recombinant N-acetylgalactosamine-4-sulfatase (Arylsulfatase B; ARSB) inhibits progression of B16F10 cutaneous melanomas and modulates cell signaling.
    Bhattacharyya S, O-Sullivan I, Tu J, Chen Z, Tobacman JK.
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan 20; 1870(1):166913. PubMed ID: 37813168
    [Abstract] [Full Text] [Related]

  • 8. Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3.
    Bhattacharyya S, Feferman L, Tobacman JK.
    J Biol Chem; 2014 Jun 20; 289(25):17564-75. PubMed ID: 24778176
    [Abstract] [Full Text] [Related]

  • 9. Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin.
    Kotlo K, Bhattacharyya S, Yang B, Feferman L, Tejaskumar S, Linhardt R, Danziger R, Tobacman JK.
    Glycoconj J; 2013 Oct 20; 30(7):667-76. PubMed ID: 23385884
    [Abstract] [Full Text] [Related]

  • 10. Increased CHST15 follows decline in arylsulfatase B (ARSB) and disinhibition of non-canonical WNT signaling: potential impact on epithelial and mesenchymal identity.
    Bhattacharyya S, Feferman L, Han X, Xia K, Zhang F, Linhardt RJ, Tobacman JK.
    Oncotarget; 2020 Jun 16; 11(24):2327-2344. PubMed ID: 32595831
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of estrogen exposure on arylsulfatase B, galactose-6-sulfatase, and steroid sulfatase in rat prostate development.
    Feferman L, Bhattacharyya S, Birch L, Prins GS, Tobacman JK.
    J Steroid Biochem Mol Biol; 2014 Sep 16; 143():105-14. PubMed ID: 24508597
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia.
    Bhattacharyya S, Tobacman JK.
    PLoS One; 2012 Sep 16; 7(3):e33250. PubMed ID: 22428001
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dihydrotestosterone inhibits arylsulfatase B and Dickkopf Wnt signaling pathway inhibitor (DKK)-3 leading to enhanced Wnt signaling in prostate epithelium in response to stromal Wnt3A.
    Bhattacharyya S, Feferman L, Tobacman JK.
    Prostate; 2019 May 16; 79(7):689-700. PubMed ID: 30801800
    [Abstract] [Full Text] [Related]

  • 15. Decline in arylsulfatase B and Increase in chondroitin 4-sulfotransferase combine to increase chondroitin 4-sulfate in traumatic brain injury.
    Bhattacharyya S, Zhang X, Feferman L, Johnson D, Tortella FC, Guizzetti M, Tobacman JK.
    J Neurochem; 2015 Aug 16; 134(4):728-39. PubMed ID: 25943740
    [Abstract] [Full Text] [Related]

  • 16. Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3).
    Bhattacharyya S, Feferman L, Tobacman JK.
    Oncotarget; 2017 Nov 21; 8(59):100242-100260. PubMed ID: 29245974
    [Abstract] [Full Text] [Related]

  • 17. N-Acetylgalactosamine-4-sulfatase (Arylsulfatase B) Regulates PD-L1 Expression in Melanoma by an HDAC3-Mediated Epigenetic Mechanism.
    Bhattacharyya S, O-Sullivan I, Tobacman JK.
    Int J Mol Sci; 2024 May 28; 25(11):. PubMed ID: 38892038
    [Abstract] [Full Text] [Related]

  • 18. Profound Impact of Decline in N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B) on Molecular Pathophysiology and Human Diseases.
    Tobacman JK, Bhattacharyya S.
    Int J Mol Sci; 2022 Oct 29; 23(21):. PubMed ID: 36361933
    [Abstract] [Full Text] [Related]

  • 19. Arylsulfatase B regulates interaction of chondroitin-4-sulfate and kininogen in renal epithelial cells.
    Bhattacharyya S, Kotlo K, Danziger R, Tobacman JK.
    Biochim Biophys Acta; 2010 May 29; 1802(5):472-7. PubMed ID: 20152898
    [Abstract] [Full Text] [Related]

  • 20. Arylsulfatase B is reduced in prostate cancer recurrences.
    Feferman L, Deaton R, Bhattacharyya S, Xie H, Gann PH, Melamed J, Tobacman JK.
    Cancer Biomark; 2017 Dec 12; 21(1):229-234. PubMed ID: 29081414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.